Efficacy and tolerability of transdermal granisetron for the control of chemotherapy-induced nausea and vomiting associated with moderately and highly emetogenic multi-day chemotherapy: a randomized, double-blind, phase III study
Steven M. Grunberg(University of Bonn), Julian Howell, Gemma Clark, Lucio Gordan(Florida Cancer Specialists & Research Institute), Ralph V. Boccia(Center for Cancer and Blood Disorders)
Cited by 87
Related Papers
Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study
|Breast Cancer Research and Treatment|2017|761
American Society of Clinical Oncology Guideline for Antiemetics in Oncology: Update 2006
|Journal of Clinical Oncology|2006|743
Recommendations for the Use of Antiemetics: Evidence-Based, Clinical Practice Guidelines
|Journal of Clinical Oncology|1999|670
Romiplostim or Standard of Care in Patients with Immune Thrombocytopenia
|New England Journal of Medicine|2010|425